Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain Impact on pain, polysomnographic sleep, daytime functioning, and quality of life
Pharmacology, Toxicology and Pharmaceutical Science
19
8%
Nursing and Health Professions
16
7%
Agricultural and Biological Sciences
11
5%
Neuroscience
8
3%
Other
24
10%
Unknown
89
38%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2026.
All research outputs
#1,470,603
of 34,566,597 outputs
Outputs from Diabetes Care
#2,041
of 13,331 outputs
Outputs of similar age
#7,632
of 233,642 outputs
Outputs of similar age from Diabetes Care
#19
of 141 outputs
Altmetric has tracked 34,566,597 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,331 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,642 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.
